These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 27699993)

  • 1. Transient elastography for the diagnosis of liver fibrosis: a systematic review of economic evaluations.
    van Katwyk S; Coyle D; Cooper C; Pussegoda K; Cameron C; Skidmore B; Brener S; Moher D; Thavorn K
    Liver Int; 2017 Jun; 37(6):851-861. PubMed ID: 27699993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transient Elastography and Controlled Attenuation Parameter for Diagnosing Liver Fibrosis and Steatosis in Ontario: An Economic Analysis.
    Thavorn K; Coyle D
    Ont Health Technol Assess Ser; 2015; 15(19):1-58. PubMed ID: 26664666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic accuracy and clinical impact of MRI-based technologies for patients with non-alcoholic fatty liver disease: systematic review and economic evaluation.
    Bresnahan R; Duarte R; Mahon J; Beale S; Chaplin M; Bhattacharyya D; Houten R; Edwards K; Nevitt S; Maden M; Boland A
    Health Technol Assess; 2023 Jul; 27(10):1-115. PubMed ID: 37839810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of non-invasive methods for assessment and monitoring of liver fibrosis and cirrhosis in patients with chronic liver disease: systematic review and economic evaluation.
    Crossan C; Tsochatzis EA; Longworth L; Gurusamy K; Davidson B; Rodríguez-Perálvarez M; Mantzoukis K; O'Brien J; Thalassinos E; Papastergiou V; Burroughs A
    Health Technol Assess; 2015 Jan; 19(9):1-409, v-vi. PubMed ID: 25633908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transient elastography for screening of liver fibrosis: Cost-effectiveness analysis from six prospective cohorts in Europe and Asia.
    Serra-Burriel M; Graupera I; Torán P; Thiele M; Roulot D; Wai-Sun Wong V; Neil Guha I; Fabrellas N; Arslanow A; Expósito C; Hernández R; Lai-Hung Wong G; Harman D; Darwish Murad S; Krag A; Pera G; Angeli P; Galle P; Aithal GP; Caballeria L; Castera L; Ginès P; Lammert F;
    J Hepatol; 2019 Dec; 71(6):1141-1151. PubMed ID: 31470067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-invasive diagnostic assessment tools for the detection of liver fibrosis in patients with suspected alcohol-related liver disease: a systematic review and economic evaluation.
    Stevenson M; Lloyd-Jones M; Morgan MY; Wong R
    Health Technol Assess; 2012; 16(4):1-174. PubMed ID: 22333291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. American Gastroenterological Association Institute Technical Review on the Role of Elastography in Chronic Liver Diseases.
    Singh S; Muir AJ; Dieterich DT; Falck-Ytter YT
    Gastroenterology; 2017 May; 152(6):1544-1577. PubMed ID: 28442120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acoustic radiation force impulse-imaging and transient elastography for non-invasive assessment of liver fibrosis and steatosis in NAFLD.
    Friedrich-Rust M; Romen D; Vermehren J; Kriener S; Sadet D; Herrmann E; Zeuzem S; Bojunga J
    Eur J Radiol; 2012 Mar; 81(3):e325-31. PubMed ID: 22119555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A health technology assessment of transient elastography in adult liver disease.
    Steadman R; Myers RP; Leggett L; Lorenzetti D; Noseworthy T; Rose S; Sutherland L; Clement F
    Can J Gastroenterol; 2013 Mar; 27(3):149-58. PubMed ID: 23516679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography.
    Imajo K; Kessoku T; Honda Y; Tomeno W; Ogawa Y; Mawatari H; Fujita K; Yoneda M; Taguri M; Hyogo H; Sumida Y; Ono M; Eguchi Y; Inoue T; Yamanaka T; Wada K; Saito S; Nakajima A
    Gastroenterology; 2016 Mar; 150(3):626-637.e7. PubMed ID: 26677985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transient Elastography for Assessment of Liver Fibrosis and Steatosis: An Evidence-Based Analysis.
    Brener S
    Ont Health Technol Assess Ser; 2015; 15(18):1-45. PubMed ID: 26664664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transient Elastography in Alcoholic Liver Disease and Nonalcoholic Fatty Liver Disease: A Systemic Review and Meta-Analysis.
    Cai C; Song X; Chen X; Zhou W; Jin Q; Chen S; Ji F
    Can J Gastroenterol Hepatol; 2021; 2021():8859338. PubMed ID: 33542909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of enhanced liver fibrosis test to assess liver fibrosis in chronic hepatitis C virus and alcoholic liver disease patients.
    Soto M; Sampietro-Colom L; Lasalvia L; Mira A; Jiménez W; Navasa M
    World J Gastroenterol; 2017 May; 23(17):3163-3173. PubMed ID: 28533673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimating steatosis and fibrosis: Comparison of acoustic structure quantification with established techniques.
    Karlas T; Berger J; Garnov N; Lindner F; Busse H; Linder N; Schaudinn A; Relke B; Chakaroun R; Tröltzsch M; Wiegand J; Keim V
    World J Gastroenterol; 2015 Apr; 21(16):4894-902. PubMed ID: 25945002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of liver fibrosis in chronic hepatitis: comparison of shear wave elastography and transient elastography.
    Paul SB; Das P; Mahanta M; Sreenivas V; Kedia S; Kalra N; Kaur H; Vijayvargiya M; Ghosh S; Gamanagatti SR; Shalimar ; Gupta SD; Acharya SK
    Abdom Radiol (NY); 2017 Dec; 42(12):2864-2873. PubMed ID: 28643136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrasound Shear Wave Elastography for Liver Disease. A Critical Appraisal of the Many Actors on the Stage.
    Piscaglia F; Salvatore V; Mulazzani L; Cantisani V; Schiavone C
    Ultraschall Med; 2016 Feb; 37(1):1-5. PubMed ID: 26871407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating feasibility and accuracy of non-invasive tests for nonalcoholic fatty liver disease in severe and morbid obesity.
    Ooi GJ; Earnest A; Kemp WW; Burton PR; Laurie C; Majeed A; Johnson N; McLean C; Roberts SK; Brown WA
    Int J Obes (Lond); 2018 Nov; 42(11):1900-1911. PubMed ID: 29463916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-utility analysis of nonalcoholic steatohepatitis screening.
    Zhang E; Wartelle-Bladou C; Lepanto L; Lachaine J; Cloutier G; Tang A
    Eur Radiol; 2015 Nov; 25(11):3282-94. PubMed ID: 25994191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid appraisal of liver diseases using transient elastography, abdominal ultrasound, and microbiology in Côte d'Ivoire: A single-center study.
    Leibenguth MT; Coulibaly JT; Silué KD; N'Gbesso YK; El Wahed AA; Utzinger J; Becker SL; Schneitler S
    PLoS Negl Trop Dis; 2024 Jun; 18(6):e0012262. PubMed ID: 38900826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-invasive assessment of liver fibrosis: Between prediction/prevention of outcomes and cost-effectiveness.
    Stasi C; Milani S
    World J Gastroenterol; 2016 Jan; 22(4):1711-20. PubMed ID: 26819535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.